Dr. Christine Allen is the inaugural Vice-President, Ecosystem Development at adMare Bioinnovations. She is a world-renowned and award-winning researcher, experienced leader and entrepreneur.

In her role as Vice-President, Ecosystem Development at adMare Bioinnovations, Dr. Allen is continuing adMare’s leadership in building a robust ecosystem for Canada’s life sciences industry through providing state-of-the-art infrastructure, scientific and commercial expertise, and investment capital to companies, enabling them to grow and maintain operations in Canada. She also oversees the adMare Academy, building the talent that the Canadian ecosystem needs to drive the growth of the life sciences sector.

Dr. Allen is a Full Professor in the Leslie Dan Faculty of Pharmacy at the University of Toronto (U of T) where she has had a stellar 20- year career as researcher and academic leader. During her time at U of T, she held increasingly senior leadership roles, most recently as inaugural Associate Vice-President and Vice-Provost, Strategic Initiatives.

Dr. Allen is a globally renowned expert in drug formulation and development with more than 150 publications to her name and numerous successful collaborations with clinical and industry partners. She is co-founder and former president of Nanovista Inc., a company focused on high-precision, image-guided cancer therapy (featured by Scientific American as one of 10 start-ups changing healthcare).

Dr. Allen is a fellow of the American Institute for Medical and Biological Engineering, incoming President of the Controlled Release Society (CRS), and past president of the Canadian Society of Pharmaceutical Sciences (CSPS). She is Editor-in-Chief of the Journal of Controlled Release, a top ranked journal in the pharmaceutical sciences field.

Follow Dr. Allen on Twitter @ChristineAllenW and Instagram @DrChristineAllen.